LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Kohler, Beatriz"
  2. AU="Tabata, Toshinori"
  3. AU="Sun, Shijing"
  4. AU="Kufeji D."
  5. AU="Kohani, Sayeh"
  6. AU="Wong, John Cm"
  7. AU="Hua LI"
  8. AU="Özkan, Yasemin"
  9. AU=Quirmbach Diana
  10. AU="Corpstein, Clairissa D"
  11. AU="Motel-Klingebiel, Andreas"
  12. AU="Brown, Randy A"
  13. AU="Feng, Yaying"
  14. AU="Lussi, A"
  15. AU="Yeon Susan B"
  16. AU="Abaci, Irem"
  17. AU="Lin, Xiaode"
  18. AU="Mendez, Luis"
  19. AU=Alzahrani Faisal A AU=Alzahrani Faisal A
  20. AU="Heidi G Standke"
  21. AU="Banville, Isabelle"
  22. AU=Morrow Lee E
  23. AU="Cuss, Chad W."
  24. AU="Carter, Paul (Interviewpartner)"
  25. AU=Lubozynski M F
  26. AU="Yves, Ville"
  27. AU="Bayer, Emily A"
  28. AU=Roesch Saskia
  29. AU="Tam, Benjamin"
  30. AU="Mori, Kousuke"
  31. AU="Steuer, Melanie"
  32. AU="Sood Hemant"
  33. AU="Jennifer Schaff"
  34. AU="Maji, Manideepa"
  35. AU=Evans Heather L
  36. AU="Cheng, Shuai"
  37. AU="Zalis, Joshua"

Suchergebnis

Treffer 1 - 2 von insgesamt 2

Suchoptionen

  1. Artikel ; Online: CT-Guided Celiac Ganglion Block for Neurogenic Gastrointestinal Dysmotility.

    Frangakis, Constantine / Kohler, Beatriz / Georgiades, Christos S

    Journal of vascular and interventional radiology : JVIR

    2022  Band 33, Heft 12, Seite(n) 1492–1499

    Abstract: Purpose: To determine whether celiac ganglion block can serve as a diagnostic test for dysautonomia as the cause of gastrointestinal dysmotility-related symptoms.: Materials and methods: This was an institutional review board-approved, prospective, ... ...

    Abstract Purpose: To determine whether celiac ganglion block can serve as a diagnostic test for dysautonomia as the cause of gastrointestinal dysmotility-related symptoms.
    Materials and methods: This was an institutional review board-approved, prospective, single-arm, registered study, from January 2020 to May 2021, and included patients aged 14-85 years with gastrointestinal symptoms of food intolerance, abdominal pain, or angina. Patients with nonneurogenic causes (ie, chronic cholecystitis, peptic ulcer disease, gastroesophageal reflux, and malabsorption syndrome) were excluded. All 15 patients underwent computed tomography-guided celiac ganglion block with 100 mg of liposomal bupivacaine. Patients filled out the dysautonomia-validated questionnaire Composite Autonomic Symptom Score 31 (COMPASS-31) before and after intervention. Differences (before vs after) were compared with the exact permutation method.
    Results: Fifteen women (median age, 17 years; range, 14-41 years) were included. Average COMPASS-31 score improved significantly, from baseline 11 (SD ± 2.8) to 4 (SD ± 1.9) (improvement, 7 points ± 2.8; P < .001). All patients reported significant reduction in abdominal angina. Fourteen of the 15 patients (93%) reported complete resolution, and 14 of 15 (93%) reported a significant reduction in non-postprandial abdominal pain (P < .01). Only 1 patient reported no improvement. Eight of those 14 patients (57%) reported complete resolution of abdominal pain. There was a significant improvement in functional scores (vomiting, P = .01; constipation frequency, P = .02; constipation severity, P < .01; and nausea, P < .01). The rate of minor and major adverse events was 13% and 0%, respectively, per the Society of Interventional Radiology adverse event classification.
    Conclusions: Celiac ganglion block is a safe diagnostic tool for confirming dysautonomia as the underlying condition in patients with gastrointestinal dysmotility-related symptoms. It could provide early diagnosis, lead to definitive treatment (ganglionectomy) earlier, or obviate unnecessary surgery.
    Mesh-Begriff(e) Humans ; Female ; Adolescent ; Prospective Studies ; Ganglia, Sympathetic/diagnostic imaging ; Abdominal Pain/etiology ; Abdominal Pain/therapy ; Tomography, X-Ray Computed/adverse effects ; Constipation/complications ; Primary Dysautonomias/complications
    Sprache Englisch
    Erscheinungsdatum 2022-08-19
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 1137756-2
    ISSN 1535-7732 ; 1051-0443
    ISSN (online) 1535-7732
    ISSN 1051-0443
    DOI 10.1016/j.jvir.2022.08.015
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Development and Preliminary Validation of the Patient-Reported Outcome Measure for Vascular Malformation Questionnaire: A Prospective Cohort Study.

    England, Ryan W / Motaghi, Mina / Kohler, Beatriz / Hemmingson, Thomas E / Wu, Albert W / Weiss, Clifford R

    Journal of vascular and interventional radiology : JVIR

    2021  Band 32, Heft 5, Seite(n) 683–690.e4

    Abstract: Purpose: To develop and validate the Patient-Reported Outcome Measure for Vascular Malformation (PROVAM) questionnaire to assess the health-related quality of life in patients with vascular malformations.: Materials and methods: We developed and ... ...

    Abstract Purpose: To develop and validate the Patient-Reported Outcome Measure for Vascular Malformation (PROVAM) questionnaire to assess the health-related quality of life in patients with vascular malformations.
    Materials and methods: We developed and validated PROVAM using a mixed methods design during a prospective clinical trial at a vascular anomalies clinic. From July 2019 to February 2020, 108 consecutive patients completed 130 questionnaires. The 30-item instrument assessed the domains of pain, emotional/social well-being, functional impact, and treatment satisfaction. Two additional items assessed ease of understanding and relevance. The primary outcomes of instrument reliability and validity were evaluated across several indices. The secondary outcome of responsiveness evaluated total score changes for patients who completed questionnaires both before and after treatment.
    Results: Instrument reliability, as measured by Cronbach alpha, was ≥0.79 for pain, emotional/social well-being, and functional impact domains. Primary domain structure was confirmed by factor analysis (P <. 001) and convergent construct validity for all but 1 Likert scale item. In the subgroup analysis of 13 participants who completed PROVAM before and after treatment, instrument responsiveness, as measured by the total score, showed a significant decrease (median, -10 points; interquartile range [IQR], -3 to -16; P = .04). Participants found the questions easy to understand (median, 5 points; IQR, 4-5 on a 5-point scale) and relevant (median score, 4; IQR, 3-5).
    Conclusions: Preliminary data support the reliability and validity of PROVAM in measuring the health-related quality of life in patients with vascular malformations.
    Mesh-Begriff(e) Adolescent ; Adult ; Child ; Emotions ; Female ; Functional Status ; Humans ; Male ; Mental Health ; Middle Aged ; Pain Measurement ; Patient Reported Outcome Measures ; Patient Satisfaction ; Predictive Value of Tests ; Prospective Studies ; Quality of Life ; Reproducibility of Results ; Social Behavior ; Treatment Outcome ; Vascular Malformations/diagnosis ; Vascular Malformations/physiopathology ; Vascular Malformations/psychology ; Vascular Malformations/therapy ; Young Adult
    Sprache Englisch
    Erscheinungsdatum 2021-03-04
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Validation Study
    ZDB-ID 1137756-2
    ISSN 1535-7732 ; 1051-0443
    ISSN (online) 1535-7732
    ISSN 1051-0443
    DOI 10.1016/j.jvir.2021.01.263
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang